Matthias MÜLLENBORN
Vice President Study Programmes, Patients & Partnerships, Global Chief Medical Office - NovoNordisk
Take off for the €2.4 Billion European Innovative Health Initiative Partnership
Wednesday 4 May 12:00 - 12:50
Matthias Müllenborn holds a Master’s Degree in Physics from the University of Münster, Germany and a PhD from UCLA, California, USA. He worked as an Associate Professor at DTU Health Tech in Denmark, and as CEO for Sonion’s MEMS microphone spin-off. From 2003 to 2017, he was with Oticon leading product development within new technologies, bone anchored hearing instruments, and cochlear implants. Matthias Müllenborn has a long experience with managing complex projects involving many internal and external stakeholders, including EU funded projects. He is leading Public-Private Partnerships at Novo Nordisk such as the IMI project Hypo-RESOLVE.
